Hydroxydaunomycin

Phase 2Small molecule

WWeill Medical College of Cornell University

Hydroxydaunomycin is one of 16 small molecule programs targeting Richter's Transformation. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Richter's TransformationRecruiting

Richter's TransformationPhase 2

Recruiting

Competition

Competitive Landscape

15 competitors in Richter's Transformation

#DrugCompanyPhaseTrials

Polivy

Roche

Phase 2

2 2

Gazyva

Roche

Phase 2

2 3

Tecentriq

Roche

Phase 2

1 4

Fludara

Sanofi

Phase 2

1 5

COLUMVI

Roche

Phase 2

1 6

Opdivo

Bristol-Myers Squibb

Phase 2

1 7

Jaypirca

Eli Lilly

Phase 2

1 8

Rituxan

Roche

Phase 2

1 9

Imbruvica

PPharmacyclics LLC.

Phase 2

2 10

Cytoxan

BBaxter Healthcare Corporation

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Phase 2Recruiting

Richter's Transformation

NCT04679012

Clinical

Trials by Indication[1]

Richter's Transformation1 trial

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

Recruiting·WWeill Medical College of Cornell University·Phase 2·NCT04679012·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Hydroxydaunomycin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hydroxydaunomycin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hydroxydaunomycin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Weill Medical College of Cornell University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: WWeill Medical College of Cornell University

Hydroxydaunomycin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Richter's Transformation1 trial

References

Drug Info

Quick Facts

Related News